Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2015 | 1 |
2016 | 1 |
2017 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
A highly virulent variant of HIV-1 circulating in the Netherlands.
Science. 2022 Feb 4;375(6580):540-545. doi: 10.1126/science.abk1688. Epub 2022 Feb 3.
Science. 2022.
PMID: 35113714
Free article.
HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome.
Boccara F, Mary-Krause M, Potard V, Teiger E, Lang S, Hammoudi N, Chauvet M, Ederhy S, Dufour-Soulat L, Ancedy Y, Nhan P, Adavane S, Steg PG, Funck-Brentano C, Costagliola D, Cohen A; PACS‐HIV (Prognosis of Acute Coronary Syndrome in HIV‐Infected Patients) Investigators †.
Boccara F, et al.
J Am Heart Assoc. 2020 Sep;9(17):e017578. doi: 10.1161/JAHA.119.017578. Epub 2020 Aug 26.
J Am Heart Assoc. 2020.
PMID: 32844734
Free PMC article.
Item in Clipboard
Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression.
Supervie V, Assoumou L, Breban R, Lert F, Costagliola D, Pialoux G, Landman R, Girard PM, Slama L; IMEA 040 DATA Study Group.
Supervie V, et al.
J Antimicrob Chemother. 2017 Nov 1;72(11):3172-3176. doi: 10.1093/jac/dkx276.
J Antimicrob Chemother. 2017.
PMID: 28961977
Clinical Trial.
Item in Clipboard
Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).
Slama L, Landman R, Assoumou L, Benalycherif A, Samri A, Joly V, Pialoux G, Valin N, Cabié A, Duvivier C, Lambert-Niclot S, Marcelin AG, Peytavin G, Costagliola D, Girard PM; IMEA 040 DATA Study Group.
Slama L, et al.
J Antimicrob Chemother. 2016 Aug;71(8):2252-61. doi: 10.1093/jac/dkw103. Epub 2016 Apr 10.
J Antimicrob Chemother. 2016.
PMID: 27068399
Clinical Trial.
Item in Clipboard
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.
Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Goujard C, Meyer L; ANRS PRIMO and COPANA Cohorts.
Krastinova E, et al.
PLoS One. 2013 Aug 1;8(8):e71473. doi: 10.1371/journal.pone.0071473. Print 2013.
PLoS One. 2013.
PMID: 23936509
Free PMC article.
Item in Clipboard
Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?
Krastinova E, Seng R, Lechenadec J, Panjo H, Essat A, Makhloufi D, Obadia M, Bernard L, Goujard C, Meyer L; ANRS PRIMO cohort.
Krastinova E, et al.
BMC Infect Dis. 2015 Apr 10;15:178. doi: 10.1186/s12879-015-0892-1.
BMC Infect Dis. 2015.
PMID: 25888386
Free PMC article.
Item in Clipboard
Cite
Cite